Abstracts tagged "chronic low back pain"

Abstract Number: 2165 • 2019 ACR/ARP Annual Meeting
Stakeholder Feedback on Novel Behavioral Intervention Targeting Comorbid Chronic Back Pain and Depression in Older Adults
Ailing Yang¹, Wei Yuet ², LaDonna Saxon ³, James LePage ³, Liana Fraenkel ⁴, Manney Reid ⁵ and Una Makris ⁶, ¹UT Southwestern Medical Center, Dallas, ²UNT Health Science Center, Fort Worth, ³Dallas VA Medical Center and UT Southwestern Medical Center, Dallas, ⁴Yale School of Medicine and VA Connecticut Healthcare System, New Haven, ⁵Weill Cornell Medicine, New York City, ⁶UT Southwestern Medical Center and Dallas VA Medical Center, Dallas
Background/Purpose: Chronic low back pain (cLBP) is the 2nd most common reason for physician visits; annual related costs exceed $100 billion and are expected to…
Abstract Number: 2171 • 2019 ACR/ARP Annual Meeting
Functional Exercise for Adults with Chronic Nonspecific Low Back Pain
Emilia Moreira¹, Anamaria Jones ¹, Eider Lima ¹, Fabio Jennings ² and Jamil Natour ², ¹Federal University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil, ²Federal University of São Paulo, São Paulo, Brazil
Background/Purpose: To assess the effectiveness of a functional exercise program for pain, functional capacity, general health, kinesiophobia, medication consumption and patient satisfaction in adults with chronic…
Abstract Number: 2766 • 2019 ACR/ARP Annual Meeting
Patient Preferences for Attributes of Treatments for Chronic Pain Associated with Osteoarthritis Pain and Chronic Low Back Pain That Differentiate Nerve-Growth Factor Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Opioids in the United States: A Discrete-Choice Experiment
Dennis Turk ¹, Marco Boeri², Lucy Abraham ³, Brett Hauber ⁴, Joanna Atkinson ³, Andrew Bushmakin ⁵, Joseph Cappelleri ⁵, Leo Russo ⁶, Lars Viktrup ⁷ and David Walsh ⁸, ¹University of Washington, Seattle, ²RTI Health Solutions, Belfast, Northern Ireland, United Kingdom, ³Pfizer, LTD, Surrey, England, United Kingdom, ⁴RTI Health Solutions, Research Triangle Park, NC, ⁵Pfizer Inc, Groton, CT, ⁶Pfizer, Inc., Collegeville, PA, ⁷Eli Lilly and Company, Indianapolis, IN, ⁸Sherwood Forest Hospitals NHS Foundation Trust, Nottingham, United Kingdom
Background/Purpose: Monoclonal antibodies that inhibit nerve growth factor (NGF-abs) may offer an alternative to current nonsteroidal anti-inflammatory drug (NSAID) and opioid treatments for osteoarthritis (OA)…
Abstract Number: 2794 • 2019 ACR/ARP Annual Meeting
Predictors of Incident and Worsening Lumbar Spine Degeneration: The Johnston County Osteoarthritis Project
Adam Goode¹, Rebecca Cleveland ², David Hu ³, Steven George ⁴, Virginia Byers Kraus ⁵, Todd Schwartz ⁶, Richard Gracely ⁷, Louis DeFrate ⁸, Joanne Jordan ⁹ and Yvonne Golightly ¹⁰, ¹Duke University, Department of Orthopedic Surgery, Duke Clinical Research Institute, and Department of Population Health Sciences, Durham, NC, ²Thurston Arthritis Research Center, Chapel Hill, NC, ³Thurston Arthritis Center, University of North Carolina - Chapel Hill, Chapel Hill, NC, ⁴Duke University, Department of Orthopedic Surgery and Duke Clinical Research Institute, Durham, NC, ⁵Duke University, Department of Orthopedic Surgery, Duke Molecular Physiology Laboratory, Durham, NC, ⁶University of North Carolina at Chapel Hill Department of Biostatistics, Chapel Hill, NC, ⁷Department of Endodontics, Adams School of Dentistry, University of North Carolina, Chapel Hill, Chapel Hill, NC, ⁸Duke University, Department of Orthopedic Surgery, Department of Mechanical Engineering and Materials Science and Department of Biomedical Engineering, Durhham, NC, ⁹University of North Carolina at Chapel Hill Thurston Arthritis Research Center, Chapel Hill, NC, ¹⁰University of North Carolina at Chapel Hill Department of Epidemiology and Thurston Arthritis Research Center, Chapel Hill, NC
Background/Purpose: Our aim was to determine whether demographics, clinical characteristics or appendicular joint osteoarthritis predict the incidence and worsening of lumbar spine disc space narrowing…
Abstract Number: 330 • 2018 ACR/ARHP Annual Meeting
The IMPACT of a Referral Algorithm for Axial Spondyloarthritis: Four Month Follow-up in Patient Reported Outcomes
Maha Jamal¹, Amber Korver², Martijn Kuijper³, Deirisa Lopes Barreto¹, Frank van den Hoogen⁴, Cathelijne W. Y. Appels⁵, Anneke Spoorenberg⁶, Bart Koes⁷, Lonneke van Hoeven⁸, JMW Hazes⁹ and Angelique EAM Weel³, ¹Maasstad Hospital, Rotterdam, Netherlands, ²Erasmuc Medical Center, Rotterdam, Netherlands, ³Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, ⁴Radboud Medical center, Nijmegen, Netherlands, ⁵Rheumatology, Amphia Hospital, Breda, Netherlands, ⁶Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ⁷Erasmuc Medical center, Rotterdam, Netherlands, ⁸Erasmus Medical center, Rotterdam, Netherlands, ⁹Rheumatology, Erasmus MC, Rotterdam, Netherlands
Background/Purpose: A substantial amount of patients with chronic low back pain (CLBP) have axial spondyloarthritis (axSpA), but early recognition of these patients is difficult for…
Abstract Number: 705 • 2016 ACR/ARHP Annual Meeting
Is a Positive Family History of Spondyloarthritis of Value in Patients with Chronic Back Pain? Results from Two Large Early Back Pain Cohorts
Zineb Ez-Zaitouni¹, Laure Gossec², Inger Jorid Berg³, Robert Landewé⁴, Maikel van Oosterhout⁵, Mariagrazia Lorenzin⁶, Maxime Dougados⁷, Désirée van der Heijde⁸ and Floris van Gaalen¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Paris 06 University and AP-HP, Hôpital Pitié Salpêtrière, Paris, France, ³Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Amsterdam Medical Center, Amsterdam, Netherlands, ⁵Rheumatology, Groene Hart Hospital, Gouda, Netherlands, ⁶Rheumatology Unit, Department of Medicine DIMED, Rheumatology Unit,University of Padova, Padova, Italy, ⁷Paris-Descartes University, Paris, France, ⁸Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: To assess whether presence of spondyloarthritis (SpA) manifestations in first- and second-degree relatives of patients with chronic back pain (CBP) is associated with higher…
Abstract Number: 708 • 2016 ACR/ARHP Annual Meeting
Development of Spondyloarthritis-Features in Patients with Chronic Back Pain over a One-Year Course: Data from the Spondyloarthritis Caught Early (SPACE)-Cohort
Zineb Ez-Zaitouni¹, Miranda van Lunteren¹, Pauline Bakker¹, Inger Jorid Berg², Robert Landewé³, Maikel van Oosterhout⁴, Augusta Ortolan⁵, Désirée van der Heijde¹ and Floris van Gaalen¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ³Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, ⁴Rheumatology, Groene Hart Hospital, Gouda, Netherlands, ⁵Rheumatology Unit, Department of Medicine DIMED, Rheumatology Unit,University of Padova, Padova, Italy
Background/Purpose: Little is known on the development of spondyloarthritis (SpA)-features over time in patients with recent onset chronic back pain (CBP). The aim was to…
Abstract Number: 2760 • 2016 ACR/ARHP Annual Meeting
Assessment of Inflammatory Back Pain and Axial Spondyloarthritis in Brazil
Sonia Lima¹, Rita Menin², Rejane Vieira³, Antonio Ximenes⁴, Valderilio Azevedo⁵, Claudia Suzuki⁶ and Flavia Heringer⁶, ¹Faculdade de Medicina do ABC, São Paulo, Brazil, ²AV. JUSCELINO K. DE OLIVEIRA,, Famerp, Sao Jose Rio Preto, Brazil, ³Hospital Geral de Fortaleza, Fortaleza, Brazil, ⁴CIP- Centro Internacional de Pesquisa, Goiânia, Brazil, ⁵Federal University of Parana and Edumed Health Research Centerand Biotech, Curitiba, Brazil, ⁶AbbVie Farmacêutica Ltda., São Paulo, Brazil
Background/Purpose: This was an observational study with retrospective (phase 1) and one-month prospective (phase 2) data collection. Medical records of subjects 18-60 years old, with…
Abstract Number: 2586 • 2014 ACR/ARHP Annual Meeting
Which Characteristics of Inflammatory Back Pain (CBP) Forecast the Presence of Sacroiliitis on Magnetic Resonance Imaging (MRI)? Results from the Esperanza Cohort
Victoria Navarro-Compán¹, Raquel Almodóvar González², Azucena Hernández³, Emma Beltrán⁴, Eugenio De Miguel⁵, Robert B. M. Landewé⁶, Désirée van der Heijde⁷ and Pedro Zarco⁸, ¹Rheumatology, University Hospital La Paz and Leiden University Medical Center, Madrid, Spain, ²Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, ³Rheumatology, Hospital Virgen de la Salud, Toledo, Spain, ⁴University General Hospital of Valencia, Valencia, Spain, ⁵Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, ⁶Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, ⁷Leiden University Medical Center, Leiden, Netherlands, ⁸Rheumatology Department, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain
Background/Purpose: CBP is often the starting point for a suspicion of axSpA. In the ASAS-criteria for axial SpA either MRI of the SI-joints or HLA-B27-testing…
Abstract Number: 585 • 2014 ACR/ARHP Annual Meeting
Optimism Levels Are Moderate and Similar in Patients with Axial Spondyloarthritis and Chronic Low Back Pain, and Are Related to Mental Quality of Life but Not Physical Quality of Life. a Cross Sectional Study of 277 Patients
Sarah Kreis^1,2,3, Anna Molto^2,3, Florian Bailly^2,3, Sabrina Dadoun^2,3, Stephanie Fabre^2,3,4, Christophe Hudry², Franck Zenasni⁵, Sylvie Rozenberg^2,3, Edouard Perthuiset⁴, Bruno Fautrel^2,6 and Laure Gossec^2,7, ¹Institut de Psychologie, Laboratoire de Psychopathologie et Processus de Santé EA4057, Université Paris Descartes, Boulogne-Billancourt, France, ²Sorbonne Universités, UPMC Univ Paris 06, GRC-08, Institut Pierre Louis d’Epidémiologie et de Santé Publique, paris, France, ³Pitié-Salpêtrière Hospital, AP-HP, Rheumatology department, paris, France, ⁴Pontoise University Hospital, pontoise, France, ⁵Institut de Psychologie, Laboratoire de Psychopathologie et Processus de Santé EA4057, Université Paris Descartes, Paris, France, Boulogne-Billancourt, France, ⁶Rheumatology, Pitie Salpetriere Hospital, Paris, France, ⁷Rheumatology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France
Background/Purpose Axial Spondyloarthritis (AxSpA) and chronic low back pain (LBP) are very different chronic rheumatic diseases in terms of physiopathology and prognosis but both have…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].